Molecular Dissection of the Gamma Secretase Complex
About the Research Project
Program
Award Type
Standard
Award Amount
$300,000
Active Dates
April 01, 2004 - March 31, 2006
Grant ID
A2004114
Summary
The neuropathological hallmark of Alzheimer’s disease (AD) is the presence of senile plaques throughout the cortex and hippocampus of affected individuals. Senile plaques are composed of extracellular deposits of a small peptide, termed beta-amyloid, or Aß. Aß is derived through the processing of a protein referred to as amyloid precursor protein (APP). There is evidence to suggest that the gene Presenilin 1 (PS1) is present as a complex with several additional membrane proteins, termed NCT, APH-1, and PEN-2. It is believed that these proteins are components of a complex required for “γ-secretase” activity, which leads to the release of the peptide from APP. However, the structural components that govern the interactions of this complex are not well understood. Dr. Sisodia has developed a model system in the yeast, Pichia pastoris, to provide a description of the structural determinants that promote the assembly of PS1, nicastrin (NCT), APH-1 and PEN-2, and to understand the order of the association of the components. This model will allow Dr. Sisodia to examine the interaction of these components and to define the minimal structural components required for the assembly of the complex. The information gained from this project could lay the groundwork for the development of new treatments that target γ-secretase and inhibit Aß production in the brain.
Grants
Related Grants
Alzheimer's Disease Research
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015
Principal Investigator
Guojun Bu, PhD
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015
Principal Investigator
Guojun Bu, PhD
Alzheimer's Disease Research
Regulatory mechanisms underlying endosomal targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Regulatory mechanisms underlying endosomal targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Alzheimer's Disease Research
Identifying Women-Specific and Men-Specific Risk Factors for Alzheimer’s Disease
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Gael Chetelat, PhD
Identifying Women-Specific and Men-Specific Risk Factors for Alzheimer’s Disease
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Gael Chetelat, PhD